Clinical Trial Update: Avutometinib and Defactinib in Diffuse Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of Avutometinib and Defactinib for diffuse gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Avutometinib (avutometinib)
• Defactinib (defactinib)

Snippet

Sponsor: Ryan H. Moy, MD, PhD | Conditions: Gastric Cancer, Stomach Cancer | Phase 2 | Status: RECRUITING